Monsanto completes acquisition of Rosetta Green assets for $35m
Monsanto said that the company's Israel operations will remain intact. Rosetta Green develops improved plant traits for agriculture using RNA technology.
Monsanto said that the company's Israel operations will remain intact and all Rosetta Green employees have accepted roles with Monsanto.
Monsanto R&D investment lead Steve Padgette said, "We're pleased to welcome the Rosetta Green team and look forward to working together on possible new applications of this exciting technology, which complements our existing research platforms."
Rosetta Green CFO Limor Zur-Stoller said, "All of us at Rosetta Green are excited to begin our work with Monsanto. Israel continues to emerge as a leader in cutting-edge technologies, and this is a great vote of confidence in our research work and scientists."
Published by Globes [online], Israel business news - www.globes-online.com - on March 6, 2013
© Copyright of Globes Publisher Itonut (1983) Ltd. 2013
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options